Bioconversion of tamoxifen by microbes

Area of Science:

• Microbiology
• Biotechnology
• Medicinal Chemistry

Background:

• Tamoxifen (TAM) is a crucial drug in breast cancer therapy.
• Understanding TAM metabolism is vital for optimizing its efficacy and minimizing side effects.
• Microbial biotransformation offers a sustainable approach to drug metabolism studies.

Purpose of the Study:

• To screen microbial cultures for their ability to metabolize tamoxifen (TAM).
• To identify and characterize the metabolites produced from TAM biotransformation.
• To explore the potential of specific microorganisms in drug metabolism research.

Main Methods:

• Screening of various microbial cultures for TAM metabolism.
• Isolation and purification of TAM metabolites.
• Chemical identification of metabolites using 2D NMR spectroscopy, gas chromatography/mass spectrometry (GC/MS), and other NMR techniques.

Main Results:

• Streptomyces rimosus ATCC 2234 uniquely metabolized TAM to 4-hydroxy tamoxifen (OHT) with a 10% yield.
• Several other microorganisms were found to transform TAM into tamoxifen-N-oxide (TNO) and desmethyltamoxifen (DMT).
• The chemical structures of OHT, TNO, and DMT were confirmed through advanced spectroscopic analyses.

Conclusions:

• Streptomyces rimosus ATCC 2234 is a promising candidate for producing 4-hydroxy tamoxifen (OHT).
• Microbial biotransformation is an effective method for generating and identifying tamoxifen metabolites.
• Further research into these microbial pathways could lead to novel therapeutic strategies or drug derivatives.